February 23, 2022 — Surge in demand for the effective diagnostic system, technological advancements, and increase in the prevalence of diseases have boosted the growth of the global PET-CT scanner device market. North America held the lion’s share in 2020, accounting for more than one-third of the market.

February 22, 2022 — A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy.

February 22, 2022 — Short bursts of radiation therapy dramatically enhanced the efficiency of targeting glioblastomas with natural nanoparticle-based immunotherapy, thus suppressing growth of the deadly tumor, inducing anti-tumor immunity and prolonging survival in animal models, a research team at Massachusetts General Hospital (MGH) has discovered.

February 18, 2022 — The Nuclear Medicine Europe (NMEu) Emergency Response Team held a call on February 14 on the unplanned HFR outage that resulted in cancellation of the planned HFR first operating cycle of 2022.

February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent Rapiscan (Regadenoson).